Looks like delta/B.1.617.2/AY.x has pretty much crushed beta/B.1.351 across many regions of Africa.
From the Genomics Africa dashboard.
In that delta (for now) seems to be usurping VOCs that appear to exhibit higher degrees of immune evasion (eg beta, mu), arguably yes. See also South America.Is this...good?
Sorry..I am assuming it is...?
In that delta (for now) seems to be usurping VOCs that appear to exhibit higher degrees of immune evasion (eg beta, mu), arguably yes. See also South America.
Until a more fit one arrives on the scene.That is encouraging.
Hopefully it will wipe out all other variants.
I was wondering about this yesterday. It seems to be policy that COVID will become endemic. What do we know about how variants play out in this picture? The flu produces variants that we produce new vaccines for each year, but is there anything about COVID that makes likely new variants more risky? Do policymakers anticipate that we will produce new vaccines for COVID like we do the flu? What are the risks of this approach?Until a more fit one arrives on the scene.
I was wondering about this yesterday. It seems to be policy that COVID will become endemic. What do we know about how variants play out in this picture? The flu produces variants that we produce new vaccines for each year, but is there anything about COVID that makes likely new variants more risky? Do policymakers anticipate that we will produce new vaccines for COVID like we do the flu? What are the risks of this approach?
The vast majority of new variants aren't "more risky", in that they don't necessarily lead to worse episodes of disease. They may (more correctly) evade immunity to a better degree and so ultimately place a higher load on healthcare systems (and cause an increase in poor outcomes to some degree).I was wondering about this yesterday. It seems to be policy that COVID will become endemic. What do we know about how variants play out in this picture? The flu produces variants that we produce new vaccines for each year, but is there anything about COVID that makes likely new variants more risky? Do policymakers anticipate that we will produce new vaccines for COVID like we do the flu? What are the risks of this approach?
Looks like delta/B.1.617.2/AY.x has pretty much crushed beta/B.1.351 across many regions of Africa.
From the Genomics Africa dashboard.
Another descendent of delta/B.1.617.2 designated - AY.4.2 - might be one to watch. It appears to be growing rapidly in the UK and Romania, with a number of cases also in Germany and Denmark. Features S:Y145H (previously seen in mu/B.617 and sometimes beta/B.1.351) plus S:A222V (seen in numerous B.1.177-related lineages which drove a lot of cases across Europe in summer 2020). Might have a fitness advantage; perhaps might even have a chance of possessing slightly elevated immune evasion.
Such concerns are an understsandable side-effect of a bad pandemic, especially at certain moments.I'm beginning to wonder if this is the end game for society as we know it
I'm beginning to wonder if this is the end game for society as we know it
Like Alpha, another gift to the world from a country where they just happily ‘let it rip’. Cunts.View attachment 292896Read and Share Twitter Threads easily!
Thread Reader helps you read and share the best of Twitter Threadsthreadreaderapp.com
Quick, scrap PCR tests for travel and put them all on the green list.Like Alpha, another gift to the world from a country where they just happily ‘let it rip’. Cunts.
Delta is pretty good at evasion already, people I know who’ve had cases round here have all been vaccinated.Its got a mutation of the spike protein-thing that means the spike is not a perfect match to exisiting antibody-thing, does this equal partial vaccine evasion?